Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 172
Selected: 0
NCT IDTitle
NCT05267613Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis.
NCT06042049A Study to Assess Safety, Pharmacokinetics Anti-Drug Antibody and Anti-RSV Antibody After 2 Doses of Nirsevimab
NCT04134728Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors
NCT06797258FlexHD® Pliable Investigation in Implant-Based Breast Reconstruction
NCT03983980Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002)
NCT04535986A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
NCT05414422A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRD
NCT03402841Multicentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed Non gBRCAm Ovarian Cancer Patients
NCT03466320DEPLETHINK - LymphoDEPLEtion and THerapeutic Immunotherapy With NKR-2
NCT05843916Switch Over Study of Biosimilar Agalsidase Beta for Fabry Disease
NCT05264506Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive
NCT03297281Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP)
NCT05632211A Study to Investigate the PK, Safety, and Tolerability Between AVT05, US and EU Simponi® in Healthy Adult Participants
NCT03627715Safety and Effectiveness of Propagermanium in Diabetic Kidney Disease Participants Receiving Irbesartan
NCT07475468CP382 - Intermittent Catheter (IC) PRO Panel Plan
NCT04188574A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail
NCT05782179Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Doses of GBS Vaccine in Elderly Participants
NCT03649152Safety and Effectiveness of Propagermanium in Focal Segmental Glomerulosclerosis Participants Receiving Irbesartan
NCT06799221Expanded Access Program for OOS Obe-cel
NCT05985083A Study Of IMM47 In Subjects With Advanced Solid Tumors
NCT03980483Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
NCT07517445Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susceptible Pulmonary Tuberculosis
NCT04568031Study of AZD1222 for the Prevention of COVID-19 in Japan
NCT05066698ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects
NCT03994328An Observational Study on Safinamide, Rasagiline and Other Standard of Care in PD
NCT05169307CPX-351 Real-World Effectiveness and Safety Study
NCT02374450A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine
NCT02734004A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.
NCT04542057A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
NCT03544281To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
NCT03628235HD-Charge: Indirect and Out-of-Pocket Costs of Huntington's Disease in the United States
NCT06559891THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
NCT06485674Long-Term Organ Damage: Anifrolumab Versus Real-World Standard of Care in Adult Patients With Active Systemic Lupus Erythematosus
NCT07430917Safety and Efficacy of J147 in Acute Ischemic Stroke
NCT04877691Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus
NCT07603193Real-World Evidence: Effectiveness and Safety of Chronic Hand Eczema Treatment With Delgocitinib Cream
NCT03622658Efficacy and Safety of Namilumab for Moderate-to-severe Axial Spondyloarthritis
NCT03285672FP-101 for the Treatment of Hot Flashes in Postmenopausal Women
NCT04605094Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic Dermatitis
NCT06951867Tezspire Cardiac Events PASS
NCT05189977A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline
NCT06498128Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ®
NCT03464019Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT).
NCT04699812Atrial Fibrillation Algorithms Clinical Validation Study
NCT04310085Study in Blood Stage Malaria Infection After DVI of Cryopreserved P. Falciparum (NF54 Strain) Sporozoites
NCT04072835Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303
NCT04718103A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype
NCT04646889Pharmacokinetic Study of AR882 in Subjects With Various Degrees of Renal Impairment
NCT02955589Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Adult T Cell Lymphoma (ATL)
NCT04744363Pharmacokinetics, Safety and Tolerability Study of AVT04 to EU Approved and US Licensed Stelara (Ustekinumab)